Product profiles

Asmasal® and Asmabec® are Clickhaler® based products.  Asmasal® contains salbutamol, a short-acting beta-2 agonist for the quick relief of asthma symptoms.  Asmabec® contains beclometasone, an inhaled steroid used as standard preventative therapy for asthma. Asmasal® and Asmabec® are marketed by Recipharm in UK, France and Ireland.

Otsuka in Japan has licensed the Clickhaler® technology from Vectura.  The device is used to deliver its short-acting beta-2 agonist Meptin® (procaterol) for the quick relief of mild, intermittent asthma symptoms.

Adept® is a 4% icodextrin solution used during surgery to prevent post-surgical adhesions, a frequent complication following gynaecological and other abdominal surgery. Adept® was licensed in a global deal with Baxter in 2006 and is now available in more than 20 countries worldwide including the key European and United States markets.

Extraneal® is a peritoneal dialysis solution containing icodextrin, used for the management of renal failure patients. Extraneal® is licensed to Baxter worldwide and marketed in more than 45 countries.

ADVATE® is a serum-free formulation of Factor VIII, a complex protein which aids blood clotting, used in the treatment of haemophilia A. It was developed by Baxter using Vectura’s intellectual property and is now marketed worldwide by Baxter.